Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPERME: Levofloxacin-Dexamethasone Aqueous Humour Penetration
NCT03740659Phase 2Completed
- Sponsor
- NTC Pharma
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of levofloxacin + dexamethasone in cataract, sponsored by NTC Pharma. Started Sep 2018; status: completed.
02
Drugs
levofloxacin + dexamethasone
03
Conditions
cataract
Beyond the preview
Go deeper on NCT03740659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740659.